// App-Quantinova.ai

397 : Treatment outcome of patients with intermediate- and poor-prognosis metastatic testicular cancer in the 2000s: A multicenter experience in Japan.

Researchers

Presenter

  • Takahiro Kojima

Principal Investigators

  • Koji Kawai

  • Kunihiko Tsuchiya

  • Tomonori Habuchi

  • Toshiaki Tanaka

  • Naoya Masumori

  • Shigeyuki Yamada

  • Yoichi Arai

  • Shintaro Narita

  • Norihiko Tsuchiya

  • Hiroyuki Nishiyama

  • Takashige Abe

  • Nobuo Shinohara

Medical Centers

  • Tohoku University Graduate School of Medicine, Miyagi, Japan

  • Department of Urology, University of Tsukuba, Tsukuba, JapanDepartment of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, JapanDepartment of Urology, Tohoku University Graduate School of Medicine, Sendai, Japan

  • Department of Radiology, Okayama University Graduate School of Medicine, Okayama, Japan

  • Department of Urologic Surgery and Andrology, Sapporo Medical University School of Medicine, Sapporo, Japan

  • Department of Radiology, Okayama University Graduate School of Medicine, Okayama, Japan

  • Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Testicular cancer

Biomarkers

  • Alpha-fetoprotein

  • Lactate dehydrogenase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved